Empowering Clinical Development With Disease Progression Modeling: Recommendations From the Clinical Trials Transformation Initiative
Evaluating the benefit–risk profile of a medical product requires comprehensive evidence that integrates information across development stages. Technological advances and broader use of real‐world data are enabling innovative quantitative paradigms characterized by greater efficiency, patient centricity, and sustainabi...